Gerard Criner
Temple Health · Temple University · Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
5
2 more share only the name and are not shown
Trial papers
111
PubMed author-name match
Trials
Studies that name Gerard Criner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07051707 · Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDNuvaira, Inc. · recruiting · COPD, Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT06933758 · Temple Health Chest Initiative (THCI 2.0)Temple University · recruiting · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
- N/ANCT06891755 · Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3Apreo Health, Inc. · recruiting · COPD, Emphysema · principal investigator
- N/ANCT05204875 · Functional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve PlacementTemple University · unknown · Emphysema · principal investigator
- N/ANCT04302272 · STRIVE Post-Market Registry StudyOlympus Corporation of the Americas · recruiting · Emphysema · principal investigator
- Ph3NCT04053634 · Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsAstraZeneca · completed · Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT03893370 · RejuvenAir® System Trial for COPD With Chronic BronchitisCSA Medical, Inc. · unknown · Chronic Bronchitis · principal investigator
- N/ANCT03030313 · Respiration Rate Monitoring in COPD PatientsResMed · completed · Pulmonary Disease, Chronic Obstructive · principal investigator
- Ph3NCT02138916 · Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryAstraZeneca · completed · Moderate to Very Severe Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT01796392 · Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)Pulmonx Corporation · completed · Emphysema · principal investigator
- Ph2NCT00630227 · Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyAeris Therapeutics · completed · Homogeneous Emphysema · principal investigator
- Ph2NCT00515164 · US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyAeris Therapeutics · completed · Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease · principal investigator
- Ph2NCT00435253 · US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyAeris Therapeutics · completed · Pulmonary Emphysema · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- IGF::OT::IGF LTRC CLINICAL CENTER - TASK ORDER 2 - 03/01/2017 - 02/28/2018 - CAN 17-847020426820160000 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 2016 to 2017 · $219,521 awarded in 2017Same name and institution; not confirmed by an ID
- Long-term Oxygen Treatment TrialN01HR76190- · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 2007 to 2016 · $6,842 awarded in 2016Same name and institution; not confirmed by an ID
- TAS:: 75 0872:: TAS LUNG TISSUE RESEACH CONSORTIUM CLINICAL CENTER26820110002 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 2011 to 2014 · $542,181 awarded in 2014Same name and institution; not confirmed by an ID
- COPD Clinical Research Network & Clinical Research Skills Core DevelopmentU10HL074408 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 2004 to 2007 · $1,086,638 awarded in 2007Same name and institution; not confirmed by an ID
- NATIONAL EMPHYSEMA TREATMENT TRIALM01RR000349 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 1998 to 1999 · $59,223 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:12 UTC. The ranking covers the 200 most relevant of 111 PubMed records, and a shared surname and initials can bring in a namesake. All 111 on PubMed
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.N Engl J Med · 2018978 citationsRCR 49.7
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.N Engl J Med · 2021970 citationsRCR 57.5
- 943 citationsRCR 44.5
- Azithromycin for prevention of exacerbations of COPD.N Engl J Med · 2011939 citationsRCR 30.3
- A randomized study of endobronchial valves for advanced emphysema.N Engl J Med · 2010628 citationsRCR 21.0
- Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.Crit Care Med · 1998537 citationsRCR 16.4
- Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.N Engl J Med · 2017523 citationsRCR 21.4
- Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.JAMA · 2004369 citationsRCR 9.4
- A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).Am J Respir Crit Care Med · 2018346 citationsRCR 18.0
- Predictors of mortality in patients with emphysema and severe airflow obstruction.Am J Respir Crit Care Med · 2006341 citationsRCR 10.3